“Proving the null hypothesis” in clinical trials

This publication has 15 references indexed in Scilit:

• Determining the probability of an important difference in bioavailability
  Clinical Pharmacology & Therapeutics, 1980
• Reporting standards and research strategies for controlled trials
  Controlled Clinical Trials, 1980
• A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis
  New England Journal of Medicine, 1979
• When can 'non significantly different' treatments be considered as 'equivalent'?
  British Journal of Clinical Pharmacology, 1979
• The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial
  New England Journal of Medicine, 1978
• The Use of Balanced Incomplete Block Designs in Comparative Bioavailability Trials
  Published by JSTOR ,1974
• Use of Confidence Intervals in Analysis of Comparative Bioavailability Trials
  Journal of Pharmaceutical Sciences, 1972
• The role of hypothesis testing in clinical trials
  Journal of Chronic Diseases, 1966
• Sodium Heparin vs Sodium Warfarin in Acute Myocardial Infarction
  Published by American Medical Association (AMA) ,1964
• IX. On the problem of the most efficient tests of statistical hypotheses
  Philosophical Transactions of the Royal Society A, 1933